Neuroblastoma, accounting for 6% of childhood cancers in the United States, is derived from sympathoadrenal progenitor cells within the neural crest (3), often develops in and around the adrenal gland, exhibits frequent genetic alterations in MYCN or ALK, and has a 5-year survival rate of 81%. This evidence concerns the gene MYCN and neuroblastoma.